Dr. Stan Pelosi is a board-certified neurotologist affiliated with Long Island Jewish Medical Center and North Shore University Hospital. His primary clinical focus is in the surgical treatment of disorders affecting the ear, including cholesteatoma, otosclerosis, chronic mastoiditis, and tympanic membrane perforation. He has expertise in performing cochlear implant surgery as well as placement of other implantable hearing devices for hearing restoration. Dr. Pelosi also is part of a multi-disciplinary team at Northwell Health that specializes in management of vestibular schwannoma and other tumors of the lateral skull base. Prior to his arrival at Northwell, Dr. Pelosi spent several years in academic practice in Philadelphia, PA. Dr. Pelosi is rated as an Advanced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Ruptured Eardrum, Hearing Loss, Infant Hearing Loss, Stapedectomy, and Myringotomy.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Acinic Cell Carcinoma of Salivary Glands, Tissue Biopsy, and Thyroidectomy.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy.

Lucio Pereira is an Otolaryngologist in New Hyde Park, New York. Dr. Pereira is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Oral Squamous Cell Carcinoma, Mikulicz Disease, Tongue Cancer, Gastrostomy, and Laryngectomy.

Dev Kamdar is an Otolaryngologist in New Hyde Park, New York. Dr. Kamdar is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy.

Dr. Laurent Ganry is an Academic Oral & Maxillofacial Surgeon (OMFS) with dual fellowship training in the USA, practicing Oncologic Head & Neck Surgery, Reconstructive Facial Surgery & Cosmetic Facial Procedure, and a third Fellowship training in Plastic surgery (Japan).He is an attending physician at the Long Island Jewish Medical Center in New York, USA, and an assistant professor at the Donal and Barbara Zucker School of Medicine at Hofstra/Northwell (Northwell Health).He earned his Medical Degree in OMFS at La Sorbonne University — College of Medicine, one of the top medical universities in Paris, France.Subsequently, he obtained Complementary Training in Facial Plastic Surgery and ENT / OMFS — Head and Neck Surgery in France, Japan, and the USA.He won Multiple Awards in Surgical Innovations and International Reconstructive Microsurgery Competitions, developed a medical device (Paten in the USA), and published over 30 scientific articles and book chapters, including one article in The Lancet Journal (one of the most prestigious medical journals).His scope of practice is:- Head and Neck Oncological Surgery - Reconstructive Facial Surgery - Benign Soft Tissue Tumors of the head and neck area- Benign Osseous Tumors and Cysts of the facial skeleton- Facial Trauma, Facial Paralysis, and Facial Sequels / Deformities Corrective Surgery- Facial Plastic Surgery (non-surgical & surgical)- Facial gender Affirming surgery. . His top areas of expertise are Basal Cell Skin Cancer, Tongue Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Bone Graft, and Osteotomy.

"Mansoor H. Beg, MD, is a surgical oncologist who joined Northwell Health's Department of Surgery in 1993. He specializes in cutaneous malignancies (cancer that begins in the outer layer of the skin) and both cancerous and noncancerous breast conditions. With 29 years of experience, Dr. Beg provides highly specialized care at Monter Cancer Center, where he treats newly diagnosed patients and those following up on their treatments.As part of a multidisciplinary team, Dr. Beg uses the most up-to-date techniques and technologies available to diagnose and treat malignant and benign conditions while minimizing discomfort and shortening recovery time. He works alongside medical oncologists, radiation oncologists, breast imaging technicians, plastic surgeons and geneticists to provide a holistic treatment plan complete with psychosocial support, physical therapy, occupational therapy and nutrition services as needed.Dr. Beg completed his residency in the Department of Surgery at North Shore University Hospital and his fellowship at Tulane University Hospital School of Medicine. Now, he is passionate about passing his knowledge on to the surgeons of the future as an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He takes part in daily resident education through the initial clinical experience (ICE) of first- and second-year medical students as well as the advanced clinical experience (ACE) of third-year students.In 2019, Dr. Beg received the Northwell Health Truly Award for Caring Touch for ""embodying compassion and having an exceptional caring touch and bedside manner."" He has also been selected as Teacher of the Year by Northwell Health Department of Surgery residents. Dr. Beg is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

"Charles Carmine Conte, MD, is a surgical oncologist with over three decades of experience. He specializes in every type of cancer, including breast cancer, gastrointestinal cancers and melanoma. Joining Northwell in 2004, Dr. Conte sees patients at Northwell Health Physician Partners Surgical Oncology at Lake Success, part of Monter Cancer Center.""Cancer doesn't follow any rules-every case is unique and complex. Dr. Conte is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Intraductal Papilloma, Inflammatory Breast Cancer, Breast Infection, Lymphadenectomy, and Pancreatectomy.

Ian Ganly is an Otolaryngologist in New York, New York. Dr. Ganly is rated as an Advanced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy.

Alec Vaezi is an Otolaryngologist in Mineola, New York. Dr. Vaezi is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Tissue Biopsy, and Thyroidectomy.

Rajiv Datta is a Surgical Oncologist and a General Surgeon in Valley Stream, New York. Dr. Datta is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Thyroid Nodule, Breast Cancer, Paget Disease of the Breast, Thyroidectomy, and Small Bowel Resection.

Eric Seitelman is a Surgical Oncologist and a General Surgeon in Valley Stream, New York. Dr. Seitelman is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, Small Bowel Resection, and Colostomy.

Snehal Patel is a General Surgeon and a Surgical Oncologist in Uniondale, New York. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Thyroid Cancer, Medullary Thyroid Carcinoma, Follicular Thyroid Cancer, Thyroidectomy, and Laryngectomy.

Zachary Schwam is an Otolaryngologist in New York, New York. Dr. Schwam has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Familial Otosclerosis, Otosclerosis, Cholesteatoma, Stapedectomy, and Mastoidectomy.

Andrew Zelenetz is an Oncologist in New York, New York. Dr. Zelenetz is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma (MCL), and Diffuse Large B-Cell Lymphoma (DLBCL).

William Kuhel is an Otolaryngologist in New York, New York. Dr. Kuhel is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Salivary Gland Tumors, Thyroid Cancer, Papillary Thyroid Cancer, Parathyroidectomy, and Gastrostomy.

David Kutler is an Otolaryngologist in New York, New York. Dr. Kutler is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Salivary Gland Tumors, Tongue Cancer, Oral Squamous Cell Carcinoma, Tissue Biopsy, and Gastrostomy.

Jay Boyle is an Otolaryngologist in New York, New York. Dr. Boyle is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Tongue Cancer, Laryngeal Cancer, Throat Cancer, Bone Graft, and Gastrostomy. Dr. Boyle is currently accepting new patients.

Hao Li is an Otolaryngologist in New York, New York. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Ear Cancer. His top areas of expertise are Otosclerosis, Familial Otosclerosis, Hearing Loss, Acoustic Neuroma, and Percutaneous Coronary Intervention (PCI).